News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-11-23 4:45:58 am BiomX: BX004 Phage Cocktail Part 2, Phase 1b/2a Clinical Results In Cystic Fibrosis Expected Any Day SeekingAlpha
2023-11-14 3:30:0 am BiomX Reports Third Quarter 2023 Financial Results and Provides Business Update GlobeNewswire
2023-10-27 5:0:0 am BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the 37th Annual North American Cystic Fibrosis Conference GlobeNewswire
2023-10-18 5:0:0 am BiomX Announces the Appointment of Edward L. Williams to its Board of Directors GlobeNewswire
2023-10-04 3:34:0 am BiomX Announces Completion of Patient Dosing in Part 2 of the Phase 1b/2a Study Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis GlobeNewswire
2023-09-07 6:0:0 am BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the European Respiratory Society (ERS) International Congress 2023 GlobeNewswire
2023-09-06 1:5:0 pm BiomX to Present at H.C. Wainwright 25th Annual Global Investment Conference GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information